Your trial data matterS

With three decades of experience, we focus on your trial outcome. As data experts, we work in your trial with the end in mind.

Click here for more information 

KOEHLER eCLINICAL:

DATA FOR DECISIONS

Central, technology-enabled, full-service study management

  • Development Consulting
  • Project Management
  • Clinical Monitoring
  • Data Management & Biostatistics
  • Own eClinical EDC & CTMS Solution Vitessa
  • FSP and Personal Leasing

Broad experience, including:

  • Medical device and IVD studies
  • Early development expertise
  • Regional and global post-marketing trials
  • Data integration, warehousing and submission readiness

Biometrical excellence since 1991

  • FSP in Biostatistics & SAS Programming
  • Statistical consulting 
  • Contribution to study design
  • Power analysis and sample size calculation
  • Randomization
  • Statistical analysis plans
  • Periodic data monitoring and safety reviews
  • Statistical modelling, analysis, reports and publication
  • HEOR including HTA

KOEHLER eClinical is proud to be a member of:

Go to article: Home | Breaking the BarrierGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: AlmacGo to article: NewsGo to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Covid-19 executive briefing by GlobalDataGo to article: Gilead’s remdesivir a candidate for US government stockpiling or bulk buying in Go to article: Covid-19’s impact on trial PROs, other endpoints can be addressed via data stratification, sensitivity analysisGo to article: ILC Dover Go to article: Vitamin D affects Covid-19 mortalityGo to article: Clinical trial disruption due to Covid-19 has begun to slowGo to article: Covid-19 boosts big bio/pharma drug sales but Regeneron may be falling shortGo to article: MimotopesGo to article: The pharma industry briefingGo to article: Charting the ups and downs of the World Health OrganizationGo to article: Road to RECOVERY: a deep dive into the world’s largest Covid-19 drug trialGo to article: Salvaging clinical trials in the time of Covid-19Go to article: Intellectual property in the time of Covid-19Go to article: Molnár-Institute Company InsightGo to article: Molnar-InstituteGo to article: A plight for sore eyes: the latest developments in seasonal allergy treatmentGo to article: How research groups are tackling the problem of biologic drug delivery Go to article: Breaking the blood-brain barrier: neurology’s greatest challengeGo to article: Timeline: charting the history of immunotherapy, cancer treatment's fourth pillarGo to article: Creating a sure data footing for AIGo to article: Koehler eClinicalGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue